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Severe acute respiratory syndrome coronavirus (SARS-CoV) infection can cause the development of severe
end-stage lung disease characterized by acute respiratory distress syndrome (ARDS) and pulmonary fibrosis.
The mechanisms by which pulmonary lesions and fibrosis are generated during SARS-CoV infection are not
known. Using high-throughput mRNA profiling, we examined the transcriptional response of wild-type (WT),
type I interferon receptor knockout (IFNAR1/), and STAT1 knockout (STAT1/) mice infected with a
recombinant mouse-adapted SARS-CoV (rMA15) to better understand the contribution of specific gene
expression changes to disease progression. Despite a deletion of the type I interferon receptor, strong expres-
sion of interferon-stimulated genes was observed in the lungs of IFNAR1/ mice, contributing to clearance of
the virus. In contrast, STAT1/ mice exhibited a defect in the expression of interferon-stimulated genes and
were unable to clear the infection, resulting in a lethal outcome. STAT1/ mice exhibited dysregulation of
T-cell and macrophage differentiation, leading to a TH2-biased immune response and the development of
alternatively activated macrophages that mediate a profibrotic environment within the lung. We propose that
a combination of impaired viral clearance and T-cell/macrophage dysregulation causes the formation of
prefibrotic lesions in the lungs of rMA15-infected STAT1/ mice.
The severe acute respiratory syndrome coronavirus (SARS-
CoV) is a highly pathogenic respiratory virus that emerged in
the human population to cause a global epidemic in 2002 and
2003. The virus infected roughly 8,000 people and resulted in
approximately 800 deaths, with high case mortality in popula-
tions of the elderly (9). In humans, SARS-CoV infection
caused mortality due to development of acute respiratory dis-
tress syndrome (ARDS) (19, 23). The lung pathology in SARS-
CoV-infected patients is believed to be caused by host immune
dysregulation as well as by viral factors (1, 28, 63).
ARDS, with a mortality rate of approximately 50%, is the
most severe form of acute lung injury and affects more than
one million people per year worldwide (32, 77). No effective
therapies for ARDS currently exist, making it a major chal-
lenge for critical-care medicine. The first phase of ARDS is the
exudative phase, presenting with diffuse alveolar damage
(DAD), inflammation, proteinaceous edema, hyaline mem-
brane formation, and severe hypoxia. This may progress to a
second phase of ARDS, the organizing phase, characterized by
pulmonary fibrosis. In addition to SARS-CoV, viruses that can
cause ARDS include influenza virus, respiratory syncytial vi-
rus, adenovirus, varicella zoster virus, human metapneumovi-
rus, and hantavirus (5, 12, 34, 37, 38, 47, 69). Mice infected
with select strains of SARS-CoV or influenza virus serve as
models for the initial exudative phase of ARDS (63, 64, 80),
but these animals do not develop pathology consistent with
later ARDS phases, and there are few infection systems that
serve as models of pulmonary fibrosis (75). Instead, most stud-
ies focused on pulmonary fibrosis utilize the bleomycin model,
which does not recapitulate the effects of a viral inducer of the
disease (50).
Several studies have shown the importance of interferon-
and STAT1-dependent signaling for reducing viral replication
as well as for limiting pathogenesis in animal models. Infection
of type I interferon receptor knockout (IFNAR1/) animals
with highly pathogenic H5N1 influenza virus results in accel-
erated mortality compared with wild-type (WT) animal results
(71). Mouse hepatitis virus, another coronavirus, causes lethal
disease in type I interferon receptor knockout mice but not in
wild-type mice (7). Likewise, STAT1/ mice exhibit dramatic
defects in the immune response, leading to mortality in re-
sponse to Listeria monocytogenes, vesicular stomatitis virus,
and herpes simplex virus infections (46, 58). In vivo treatment
with interferon reduces SARS-CoV replication and lung pa-
thology in macaques, suggesting that the innate immune re-
sponse does protect animals from SARS-CoV pathogenesis
(29).
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Previous gene expression studies of SARS-CoV in model
systems have provided some insight into the mechanism of
pathogenesis. Initial studies using macaques infected with sub-
lethal inoculums revealed a strong innate immune response
that corresponded with peak viral replication and a later pro-
liferative response associated with increased expression of cell-
division genes and the healing of the damaged tissue (17).
Further studies of lethal SARS-CoV infection in aged mice
revealed an accelerated upregulation of acute-phase response
genes associated with ARDS, including the cytokines interleu-
kin-1 beta (IL-1), IL-6, and tumor necrosis factor alpha
(TNF-) (63). However, infection with clinical isolates of
SARS-CoV did not cause significant lung disease in young
mice and resulted in delayed upregulation of immune response
genes compared with the results seen with aged mice. To
enable routine studies of SARS-CoV pathogenesis, mouse-
adapted SARS-CoV strains have been developed using serial
passage techniques (16, 52, 62). The first of these strains,
designated rMA15 (representing a recombinant mouse-
adapted SARS-CoV), contains 6 mutations with respect to the
Urbani clinical isolate of SARS-CoV (62). Both young and
aged mice infected with rMA15 develop lung pathology, and
several strains of mice succumb to infection. Using this virus,
we have been able to infect young mice and elicit ARDS
pathophysiology (61).
Our previous work (24) revealed that young type I interferon
receptor knockout (IFNAR1/) mice did not exhibit in-
creased pathogenesis as a result of rMA15 infection compared
to wild-type (WT) mice. However, rMA15 infection of young
STAT1/ mice resulted in increased pathology, including ev-
idence of pulmonary fibrosis-like lesions and mortality by 9
days postinfection (dpi). In this work, we extended the initial
biological characterization of rMA15 infection in WT,
IFNAR1/, and STAT1/ mice by using microarray profil-
ing, immunohistochemistry, and cell-sorting techniques to ex-
amine the molecular mechanisms governing severe end-stage
lung disease. We found that STAT1/ mice infected with
rMA15 exhibited a shift to a TH2 response, with expansion and
activation of alternatively activated M2 macrophages, resulting
in fibrosis-like protein deposition in the lungs.
MATERIALS AND METHODS
Mouse infection. 129S6/SvEv (abbreviated here as “129”) wild-type and
STAT1/ mice (catalog number 002045-M-F) were obtained from Taconic
Farms (Germantown, NY). IFNAR1/ mice bred on a 129SvEv background
were a gift from Mark Heise (University of North Carolina [UNC]-Chapel Hill)
and were bred at the University of North Carolina mouse facility (Chapel Hill,
North Carolina). All animal studies were conducted using animal biosafety level
3 laboratories and Sealsafe cages with HEPA filters, and personnel wore per-
sonal protective equipment, including Tyvek suits and hoods as well as positive-
pressure air respirators with HEPA filters. Ten-week-old mice were anesthetized
with a ketamine (1.3 mg/mouse)-xylazine (0.38 mg/mouse) mixture administered
intraperitoneally in a 50-l volume. Mice were infected intranasally with either
phosphate-buffered saline (PBS) alone (Invitrogen, Carlsbad, CA) or 1  105
PFU rMA15–PBS. A total of 5 infected mice from each strain were euthanized
at days 2, 5, and 9 postinfection (dpi) for virological, histological, and microarray
analyses. Mock-infected animals from each of the strains were euthanized at 5
dpi. Samples from the right lung were reserved for viral titers and histology, and
the entire left lung was reserved for microarray analyses. Animal housing, care,
and experimental protocols were in accordance with all UNC-Chapel Hill Insti-
tutional Animal Care and Use Committee guidelines.
RNA preparation and oligonucleotide microarray processing. The entire left
lung of each mouse was dissected and homogenized using Trizol and a Magnal-
yser system (Roche) according to manufacturer instructions. RNA was further
purified using RNeasy columns (Qiagen) according to manufacturer instructions.
RNA samples were spectroscopically verified for purity, and the quality of the
intact RNA was assessed using an Agilent 2100 Bioanalyzer. For each set of
treatment conditions, 3 of the 5 RNA samples exhibiting the highest RNA
integrity number (RIN) determined using the Bioanalyzer were used for mi-
croarray analysis. cRNA probes were generated from each sample by the use of
an Agilent one-color Quick-Amp labeling kit. Individual cRNA samples were
hybridized to Agilent mouse whole-genome oligonucleotide microarrays (4 44)
according to manufacturer instructions. Samples from individual animals were
not pooled to enable examination of animal-to-animal variations as part of the
data analysis. Select samples were hybridized a second time (n  2 technical
replicates) to verify the quality of the process. Slides were scanned with an
Agilent DNA microarray scanner, and the resulting images were analyzed using
Agilent Feature Extractor software. Data were warehoused in a Katze Labkey
system (Labkey, Inc., Seattle, WA) and analyzed using Resolver 7.1 software
(Rosetta Biosoftware, Seattle, WA), and Spotfire DecisionSite for Functional
Genomics 9.1 software (Tibco Spotfire, Somerville, MA). Primary data are avail-
able (http://viromics.washington.edu) in accordance with proposed Minimum
Information About a Microarray Experiment (MIAME) standards.
Analysis of microarray data. An initial analysis of gene expression in each
mouse line was performed as a function of time (kinetic analysis). Genes were
selected based on textbook analysis of variance (ANOVA) of microarray inten-
sity scores, with a significance criterion of P  0.05. The following infection
groups (n  3 per group) were compared for WT, IFNAR1/, and STAT1/
mice, for a total of 9 gene lists: mock and 2 dpi, 2 dpi and 5 dpi, and 5 dpi and
9 dpi. These gene lists were reduced by requiring a change of at least 1.5-fold
between the group averages. Genes that met these criteria were characterized
using Ingenuity Pathways Analysis (IPA) (Ingenuity Systems, Redwood City,
CA) functional annotations. Functional annotations were scored using the Fisher
exact test. Subsequent analysis was performed to better understand the differ-
ences between strains. Textbook ANOVA was performed on the ratio data (i.e.,
ratios determined with respect to the averages of the strain-matched mock-
infected sample results) at 2 dpi. The following comparisons of mouse groups
were performed: WT versus IFNAR1/, WT versus STAT1/, and
IFNAR1/ versus STAT1/. As described above, a significance criterion of
P  0.05 was applied. The gene lists were trimmed by requiring that the change
of at least one ratio comparing mock results was greater than 1.5-fold. The gene
lists were then split based on the sample that exhibited the greater magnitude of
change, yielding 6 gene lists based on both ANOVA and the relative differential
regulation results for the mouse groups, as follows: genes that are differentially
regulated more in WT than in IFNAR1/, more in IFNAR1/ than in WT,
more in WT than in STAT1/, and so forth. As described above, these gene lists
were functionally annotated using IPA. This process was repeated for data
obtained at 5 dpi. The resulting top 5 statistically significant canonical pathways
for each gene list are shown (see Table 2). Additional analysis of interferon-
stimulated genes (ISGs) was performed using a panel of genes induced in the
lungs of WT mice upon intranasal stimulation with 10,000 units of interferon
alpha for a 24-h time period (14). Gene lists characteristic of TH1 and TH2
immune responses were derived from annotations from the SABiosciences and
NCBI Entrez Gene databases. Gene lists characteristic of M1 and M2 activated
macrophages were derived from the work of Mantovani and coworkers (45) and
NCBI Entrez Gene.
Masson’s trichrome staining. Lung tissues were fixed in PBS–4% paraformal-
dehyde (pH 7.3) and embedded in paraffin, and 5-m-thick sections were pre-
pared by the UNC histopathology core facility. Prior to use, sections were
deparaffinized in xylene with 2 changes of 5 min each and washed with water.
Slides were left to incubate overnight in picric acid at room temperature. Slides
were then washed in running tap water for 10 min to remove the yellow color and
rinsed with deionized water. The slides were then incubated in Weigert’s iron
hematoxylin solution (catalog number HT079; Sigma) for 10 min. After incuba-
tion, slides were washed in running water for 10 min and rinsed in deionized
water. The slides were then incubated in Biebrich scarlet-acid fuschin solution
(catalog number HT151; Sigma) for 5 min and washed in deionized water. After
the washing was performed, the slides were incubated in phosphomolybdic-
phosphotungstic acid (catalog number F9252; Sigma) for 10 min and then in
aniline blue for 5 min (catalog number 415049; Sigma) before being rinsed in
deionized water. The slides were then fixed in 1% acetic acid for 3 min followed
by two rinses of 95% and 100% ethanol and a final xylene rinse.
Immunohistochemistry. Lung tissues were fixed in PBS–4% paraformalde-
hyde (pH 7.3) and embedded in paraffin, and 5-m-thick sections were prepared
by the University of Maryland histopathology core facility. Sections were depar-
affinized in xylene, with 2 washes of 5 min each. The slides were then placed in
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absolute alcohol and in 95% and 70% alcohol, with 2 washes of 2 min each. After
2 washes in PBS, the slides were immersed in methanol–0.3% H2O2 for 30 min
to quench the endogenous peroxidase. The slides were then preincubated with
10% goat serum for 20 min at room temperature followed by incubation with
primary antibody for 1 h at room temperature. Rabbit anti-arginase I (Santa
Cruz Biotechnology, Santa Cruz, CA) was used at a 1:50 dilution, polyclonal
rabbit anti-YM1 (StemCell Technologies, Vancouver, BC, Canada) was used at
a 1:200 dilution, and monoclonal rat anti-Mac3 (Cedarlane Laboratories, Burl-
ington, NC) was used at a 1:500 dilution. Slides were washed 3 times in PBS, and
biotin secondary antibody was applied for 30 min at room temperature. The
sections were washed in PBS 3 times and incubated with ABC reagent (Vector
Laboratories Inc.). After 2 changes of PBS, DAB (3,3-diaminobenzidine) was
used to develop the sections, which were then counterstained with Mayer’s
hematoxylin for 2 min. Slides were dehydrated in 2 changes of 95% and absolute
alcohol and then mounted with coverslips.
Quantitative RT-PCR. Relative quantitative reverse transcription-PCR (RT-
PCR) was performed to validate a number of gene expression changes as de-
tected with microarrays. A QuantiTect reverse transcription kit (Qiagen Inc.,
Valencia, CA) was used to generate cDNA, and quantitative RT-PCR was
performed using an Applied Biosystems 7500 PCR system. The following
TaqMan assays for mouse genes were obtained from Applied Biosystems: for
Igf1, assay Mm00439560_m1; for Ccl11, assay Mm00441238_m1; for Arg1, assay
Mm00475988_m1; for Il17a, assay Mm00439619_m1; and for Col3a1, assay Mm
01254476_m1. The TaqMan assay for SARS nucleoprotein (NP) was described
previously (39). Loading variations were normalized using the invariant calibra-
tor gene Mfap-1a according to the 2CT threshold cycle method (41). Differ-
ences in gene expression are represented as log ratios relative to cDNA samples
from strain-matched mock-infected animals.
FACS analysis of alternatively activated macrophages (AAMs). Ten-week-old
129SvEv and STAT1/ mice (Taconic Laboratories) were infected with 105
PFU of rMA15 as described previously. Mice were euthanized at day 8 postin-
fection and their lungs dissected for fluorescence-activated cell sorter (FACS)
analysis. Lungs of the mice were dissociated in collagenase and DNase, after
which the cells were incubated with PerCP-Cy5.5-labeled anti-CD11b (eBio-
science, San Diego, CA) and phycoerythrin-labeled anti-CD14 (eBioscience, San
Diego, CA). Cells were permeabilized and stained with anti-Mac3 (Cedarlane
Laboratories Ltd., Burlington, NC) and then with allophycocyanin-labeled goat
anti-rat IgG (Biolegend, San Diego, CA). Samples were processed on a Becton
Dickinson LSR II FACS machine and analyzed using FlowJo 7.6.
RESULTS
To better understand the contributions of specific signaling
pathways and gene expression changes to SARS-CoV-induced
lung disease, we examined the global transcriptional changes
that occur during rMA15 infection of WT mice or mice con-
taining genetic defects associated with innate immune signal-
ing. WT, IFNAR1/, and STAT1/ mice were infected with
1 105 PFU of rMA15. Five animals per group were sacrificed
at 2, 5, and 9 dpi. Weight loss, tissue pathology, and viral titer
data are shown in Fig. 1 and 2 and Table 1; a detailed descrip-
tion of the disease course was previously reported (24). Briefly,
WT and IFNAR1/ mice experienced similar disease courses
based on viral titer, weight loss, and lung pathology results. WT
and IFNAR1/ mice lost 15% of their starting weight by 5 dpi
but regained this weight by 9 dpi. Peak viral titers in the lung
for both mouse strains were observed at 2 dpi and diminished
over the course of the infection. At 9 dpi, virus was not de-
tectable by plaque assay or by in situ hybridization.
STAT1/ mice exhibited weight loss and pathology similar
to the results seen with the WT and IFNAR1/ mice at 2 dpi
but experienced increased weight loss and inflammatory cell
infiltration into the lungs at 5 and 9 dpi. Notably, extensive
collagen deposition was observed in the lungs of STAT1/
mice by Frieman et al. (24) and in this work as judged by
Masson’s trichrome staining (Fig. 3), suggesting early-stage
pulmonary fibrosis. STAT1/ mice also exhibited higher viral
titers in the lung throughout the time course, including 5 106
PFU per gram of tissue at 9 dpi. Gene expression profiling
analyses of RNA samples from 3 of the 5 mice per group were
used to identify mechanisms of protection against rMA15 ex-
hibited by wild-type and IFNAR1/ mice and to identify the
pathological mechanisms that lead to fibrosis-like disease in
the STAT1/ mice, as described in the following sections.
Immune and mitotic gene expression reveals common anti-
viral response and damage repair mechanisms. We began our
gene expression studies by performing ANOVA of gene ex-
pression data obtained from the lungs of WT, IFNAR1/,
and STAT1/ mice. ANOVA identifies genes for which the
variation in expression levels between biological replicates is
significantly smaller than the variation between different treat-
ment groups (based on either time or mouse strain). We initially
focused on identifying functional gene classes that were associ-
ated with the progression of rMA15 infection and pathology. To
accomplish this, we performed three comparisons for each strain:
(i) expression data from mock-infected animals were compared
with expression data from infected animals sacrificed at 2 dpi; (ii)
expression data from infected animals sacrificed at 2 dpi were
compared with expression data from infected animals sacrificed at
5 dpi; and (iii) expression data from infected animals sacrificed at
5 dpi were compared with expression data from infected animals
sacrificed at 9 dpi.
Using IPA to evaluate the gene sets determined using our
ANOVA results, we identified responses common to rMA15-
infected WT, IFNAR1/, and STAT1/ mice relative to
mock-infected animals. The commonly identified response at 2
dpi consisted of a set of genes involved in immunity and the
inflammatory response to infection that were annotated by the
IPA “immunological disease” functional category. WT mice
differentially regulated 183 genes (P  1.85  1036),
IFNAR1/ mice differentially regulated 230 genes (P 
4.36 1011), and STAT1/ mice differentially regulated 202
genes (P  8.30  1045) in this category. A union of these
genes is shown as a heat map in Fig. 4 (top panel). Increased
expression of a subset of these genes at 2 dpi, including genes
encoding cytokines (Il1a, Il1b, Il6, Il10, Il12b, and Tnf), che-
mokines (Ccl2, Ccl3, Ccl4, Ccl7, Ccl20, Cxcl2, Cxcl3, and
Cxcl10), and immune sensor molecules (Tlr1, Tlr2, and Tlr3),
suggested a common initial immune and inflammatory re-
FIG. 1. Viral replication in the lungs of wild-type and knockout
mice. Lung viral titer data from 5 mice infected with rMA15 per strain
per time point are shown. The limit of detection for this assay is 5 
102 PFU.
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sponse in all three strains of mice (Fig. 4, top panel [yellow
box]) (individual genes are listed in Table S1 in the supple-
mental material).
By 5 dpi, the mRNA abundance of these same immune-
related genes was reduced in WT and IFNAR1/ mice, which
correlated with the reduced pathology seen with these animals.
In contrast, expression of this gene set in STAT1/ mice was
increased at 5 dpi, reflecting an observed increase in inflam-
mation. At 9 dpi, expression of immune-related genes was
further reduced in WT and IFNAR1/ mice whereas expres-
sion of these genes was still significantly increased in
STAT1/ mice. This may reflect the extensive immune cell
infiltration observed in the lungs of these animals (24).
Our ANOVA and IPA results also suggested the presence of
extensive cell proliferation by 5 dpi. In particular, the IPA “cell
stage” functional category was strongly associated with this
FIG. 2. Sustained inflammation in the lungs of STAT1/ mice infected with rMA15. Representative tissue samples from WT, IFNAR/, and
STAT1/ mice infected with rMA15 or mock-infected (2, 5, and 9 dpi) were stained with hematoxylin and an eosin counterstain. Images at lower
magnification are available in Fig. S1 in the supplemental material. Magnification, 40.
TABLE 1. Summary of clinical and virological measures
Characteristic
Value for indicated mouse straina
129 IFNAR1/ STAT1/
Time of maximum weight loss (dpi) 4 4 9
Maximum wt loss (% of starting wt) 14–16 14–16 	20
Peak viral titer (PFU/g) 2.6–3.8  107 3–7.2  107 7.6  107–3.4  108
Viral RNA level at 2 dpi 6.4–16  104 1.4–2.8  105 8.9–23  104
Viral RNA level at 5 dpi 1.2–20  102 3.7–25  102 3.1–4.4  104
Viral RNA level at 9 dpi 1.0–7.5 5.2–84 5.5–9.5  103
Alveolar protein deposition at 9 dpi No No Yes
Endpoint Recovery Recovery Death
a The ranges of viral RNA levels are shown on an arbitrary scale as determined by quantitative RT-PCR results determined using probes for the SARS nucleoprotein
gene (39). Three animals were used per set of conditions and time point.
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time point. WT mice differentially regulated 171 genes (P 
1.05  1030), IFNAR1/ mice differentially regulated 185
genes (P  1.82  1019), and STAT1/ mice differentially
regulated 160 genes (P  4.71  1014) in this category.
Expression of a union of these genes is shown in Fig. 4 (lower
panel). Of particular interest are members of a subset of these
genes that exhibit low expression at 2 dpi and high expression
at 5 dpi, with the results being independent of the mouse strain
(Fig. 4, cyan box). These genes include DNA damage repair-
associated genes (Brca1, Rad51, and Rad54l), cyclins (Ccna2,
Ccnb1, Ccne1, Ccne2, and Ccnf), cell division cycle genes
(Cdc6, Cdc20, Cdc25c, Cdca5, and Cdca8), and genes associ-
ated with DNA replication initiation (Mcm10 and Pole). A full
list of these genes is included in Table S2 in the supplemental
material. In particular, IFNAR1/ mice exhibited the stron-
gest expression of these genes, suggesting that more cell divi-
sion occurs in these animals at 5 dpi. By 9 dpi, the expression
of these genes was reduced in WT and IFNAR1/ mice,
suggesting a decrease in cell proliferation as the virus was
cleared. In contrast, STAT1/ mice exhibited a further in-
crease in gene expression associated with the cell cycle at 9 dpi.
This may have been due to proliferation of fibroblasts or cell
division of infiltrating immune cells.
Differential host response patterns suggest mechanisms of
pathogenesis and survival. In order to reveal the differences in
the host response that underlie the inability of STAT1/ mice
to clear the virus and the subsequent development of pulmo-
nary fibrosis-like lesions, we performed ANOVA to identify
genes that were differentially expressed based on the mouse
strain. These genes were then functionally annotated using
pathway information from IPA. Table 2 contains the pathways
most significantly enriched in the ANOVA gene lists from 2
dpi. Genes associated with the interferon signaling pathway,
including Ifi35, Ifit1, Ifit3, Irf1, Irf9, Jak2, Med14, Oas1,
Psmb8, Socs3, Stat1, Stat2, and Tap1, were robustly upregu-
lated in WT or IFNAR1/ mice compared with STAT1/
mice (Table 2).
Since most of the genes noted above are induced in response
to interferon stimulation, we compared our ANOVA gene list
with a more comprehensive list of genes that have been shown
to be upregulated in mice treated intranasally with interferon
alpha (see Materials and Methods and reference 14). We iden-
STAT1-/- + PBS STAT1-/- + rMA15
10X
40X
FIG. 3. Abnormal protein deposition in the lungs of STAT1/
mice infected with rMA15. Representative tissue samples from
STAT1/ mice infected with rMA15 or subjected to mock infection (9
dpi) were stained with Masson’s Trichrome. The presence of blue-
purple staining indicates protein deposition in the alveolar spaces.
Images at lower magnification are available in Fig. S2 in the supple-
mental material.
FIG. 4. Kinetics of the transcriptional response to infection corre-
late with pathological findings. Expression profiles of 261 immune-
related genes (top) and 204 cell cycle-related genes (bottom) selected
by ANOVA are shown. Each column represents averages of data from
the results of 3 replicate animal experiments performed using WT,
IFNAR1/, or STAT1/ mice at 2, 5, or 9 dpi compared to averages
of data from experiments performed using mock-infected mice of the
same strain. Genes shown in red were upregulated, genes shown in
green were downregulated, and genes shown in black indicate no
change in expression relative to mock-infected mice. Genes in the top
panel were identified as part of the IPA “immunological disease”
functional category in at least one ANOVA comparison between
mock-infected animals and animals sacrificed at 2 dpi. A yellow box
highlights 81 genes similarly upregulated by the 3 strains at 2 dpi. The
identities of these genes are listed in Table S1 in the supplemental
material. Genes in the lower panel were identified as part of the IPA
“cell stage” functional category in at least one ANOVA comparison
between mice sacrificed at 2 and at 5 dpi. A cyan box highlights 80
genes commonly upregulated by all strains of mice by 5 dpi. The
identities of these genes are listed in Table S2 in the supplemental
material.
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tified 268 interferon-stimulated genes that were more strongly
induced or repressed in WT or IFNAR1/ mice than in
STAT1/ mice (Fig. 5, orange and yellow bars). Genes an-
notated with an antiviral function were most significantly en-
riched in this gene set (Fig. 5, yellow bar), suggesting that
signaling independent of the type I interferon receptor, but
dependent on STAT1, activates interferon-stimulated gene
(ISG) expression during rMA15 infection, including expression
of genes required for clearance of rMA15. Such signaling could
be the result of interferon lambda production. Il28b (inter-
feron lambda 3) is modestly induced at 2 dpi, averaging 4.5-
fold induction in 129 mice, 7.4-fold induction in IFNAR1/
mice, and 10.2-fold induction in STAT1/ mice but not at
later time points (data not shown). This level of induction is
modest compared with the more than 10-fold induction seen
with a number of type I interferons at 2 dpi (data not shown).
In contrast, only 48 ISGs were identified as being more
strongly induced in STAT1/ mice than in WT or
IFNAR1/ mice (Fig. 5, blue and cyan bars). Many of these
genes are involved in leukocyte trafficking (Fig. 5, cyan bar). In
particular, S110a9, Csf3r, Mmp8, Cxcl1, Saa1, Cxcl10, Ccl7,
and Il6 gene expression is associated with neutrophil infiltra-
tion (4, 10, 22, 48, 55, 74), Ccl8 and Ccl11 are associated with
eosinophilia (10), and Ccl4 is associated with macrophage ac-
tivation (20). Notably, levels of neutrophils, eosinophils, and
macrophages were elevated in the lungs of STAT1/ mice
infected with rMA15 (24). These results suggest that leukocyte
infiltration of the lung is the main antiviral response available
to STAT1/ mice in the absence of effective ISG induction.
Although these genes were identified as stimulated by inter-
feron, many of these genes are also activated by other proin-
flammatory signaling pathways, most notably AP-1 and NF
B
(18, 54, 72).
STAT1/ mice exhibit induction of genes associated with
leukocyte recruitment, TH2 bias, and fibrosis. In order to un-
derstand the regulatory patterns associated with the increased
pathogenesis of rMA15 in STAT1/ mice, we examined those
genes selected by ANOVA with the STAT1/ and WT or
IFNAR1/ datasets (described above) that exhibited greater
differential regulation in STAT1/ mice. At 2 dpi, this anal-
ysis revealed a significant enrichment for genes associated with
leukocyte trafficking (Table 2). In addition, eosinophilic che-
mokine Ccl24 and TH2 signaling transcripts (Csf3, Il5, and Il9)
were identified. The involvement of TH2-associated genes was
TABLE 2. Top differentially expressed pathways at 2 dpi
Gene regulation comparison for




129 more regulated than IFNAR1/ Acute-phase response signaling 15 4.3
LXR/RXR activation 9 4.1
FXR/RXR activation 10 4.0
TREM1 signaling 8 4.0
Hepatic cholestasis 11 3.1
129 more regulated than STAT1/ Pattern recognition receptors in recognition of bacteria and viruses 21 7.6
Interferon signaling 11 5.9
Allograft rejection signaling 12 5.3
Antigen presentation pathway 11 5.3
Graft-vs-host disease signaling 12 5.2
IFNAR1/ more regulated than 129 Valine, leucine, and isoleucine degradation 25 7.4
Propanoate metabolism 21 5.9
LPS/IL-1-mediated inhibition of RXR function 43 4.9
-alanine metabolism 18 4.8
Pyruvate metabolism 22 4.8
IFNAR1/ more regulated than STAT1/ Valine, leucine, and isoleucine degradation 28 8.9
Propanoate metabolism 23 6.1
Pyruvate metabolism 23 5.5
-alanine metabolism 18 4.4
Interferon signaling 12 4.1
STAT1/ more regulated than 129 Arginine and proline metabolism 9 4.3
Urea cycle and metabolism of amino groups 6 4.2
Bile acid biosynthesis 7 4.0
IL-10 signaling 7 3.2
Complement system 5 2.9
STAT1/ more regulated than IFNAR1/ LXR/RXR activation 9 6.2
Acute-phase response signaling 12 5.2
IL-10 signaling 7 4.6
Cytokine mediation of communication between immune cells 6 3.9
Hepatic cholestasis 9 3.8
a Lists of differentially expressed genes were determined as described in Materials and Methods and were investigated using IPA. The 5 top-scoring canonical
pathways are shown.
b LXR, liver X receptor; RXR, retinoid X receptor; FXR, farsenoid X receptor; LPS, lipopolysaccharide.
c Enrichment scores are calculated as log(P value). The P value is derived from Fisher’s exact test as described in Materials and Methods.
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unexpected in the context of an acute viral infection of naïve
animals. TH2 responses are associated with humoral immunity
to bacteria and viruses, wound healing, and helminth infection,
whereas clinical and experimental SARS infections are gener-
ally characterized by a TH1 immune response (40, 63). In
addition, STAT1/ mice exhibited increased gene expression
associated with the arginine-proline metabolism pathway at 2
dpi (Table 2), including inducible arginase (Arg1), a marker
for profibrotic “alternatively activated macrophages,” as de-
scribed in detail below.
Of particular significance, numerous genes associated with
the development of fibrosis were differentially induced by
STAT1/ mice compared with WT and IFNAR1/ mice at
5 dpi (Fig. 6), including mediators of inflammation (Ccl2,
Cxcl3, Ifng, Il1a, Il1b, Il6, Nfkb2, and Tnf) and tissue remod-
eling (Igf1, Igfbp4, Igfbp3, Timp1, Timp2, Mmp9, Mmp13,
Fn1, and Col3a1). These results suggested that we were able to
detect the activation of profibrotic gene expression several days
prior to observing a fibrotic phenotype in the infected lung; we
previously observed a similar phenomenon in the context of he-
patic fibrosis caused by hepatitis C virus (68). RT-PCR validation
performed using Col3a1 and Igf1 confirmed this pattern of gene
expression (data not shown). Fibrosis genes included extracellular
matrix proteins (Col3a1 and Fn1), metalloprotease inhibitor
Timp1, and insulin-like growth factor (Igf1), which have previ-
ously been implicated as hallmarks of pulmonary fibrosis progres-
sion in the bleomycin model (11, 43, 70).
Knockout mice exhibit a bias in T-helper and macrophage
differentiation. Because several genes identified in the time-
FIG. 5. Deviant interferon response in STAT1/ mice. Expression
profiles are shown for interferon-stimulated genes (identified by intrana-
sal administration of 10,000 units of interferon alpha for 24 h) (see details
in Materials and Methods and reference 14) that were significantly dif-
ferent between STAT1/ mice and WT or IFNAR1/ mice as judged
by ANOVA. Each column represents gene expression data from an av-
erage of 3 animal replicate experiments compared to mock-infected ani-
mal results. Genes shown in red were upregulated, genes shown in green
were downregulated, and genes shown in black indicate no change in
expression relative to mock-infected animal results. Genes are marked
according to whether greater differential regulation was observed in
STAT1/ mice (blue and cyan) or in WT and IFNAR1/ mice (orange
and yellow). Genes marked with a cyan bar were functionally annotated as
involved with “cell movement of leukocytes” by IPA (14 genes; P 
8.61  1011). Genes marked with a yellow bar were functionally anno-
tated as “antiviral response” genes by IPA (18 genes; P  8.58  1012).
Genes in these functionally annotated categories are listed by Entrez
Gene name. Genes comprising this heat map are listed in Table S3 in the
supplemental material.
FIG. 6. Increased fibrotic gene expression in STAT1/ mice. Ex-
pression profiles are shown for 48 genes associated with the IPA
“hepatic fibrosis” canonical pathway. The heat map is colored accord-
ing to the ratio of gene expression at 5 dpi to that seen with mock-
infected mice. Red indicates upregulation, green indicates downregu-
lation, and black indicates no change in expression upon infection.
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matched ANOVA were associated with a TH2 immune re-
sponse, we investigated gene regulation associated with the
TH1/TH2 balance in greater detail. Expression levels for TH1-
associated genes (Fig. 7A) were similar in all mouse strains at
2 dpi. However, the STAT1/ mice exhibited stronger induc-
tion of TH1 genes at 5 and 9 dpi compared with WT and
IFNAR1/ mice. This may reflect the ongoing viral replica-
tion and activation of the TH1 master regulator T-bet in the
lungs of STAT1/ mice. In contrast, whereas WT and
IFNAR1/ mice exhibited little regulation of TH2-associated
gene expression, STAT1/ mice exhibited significant induc-
tion of several TH2 genes, including Il5, Il9, Ccl7, Ccl11, Ccl24,
and Csf3 (Fig. 7A, yellow box). RT-PCR performed on Ccl11
confirmed this pattern of gene regulation (data not shown).
These data suggest that STAT1/ animals experience a TH2
bias compared with WT mice.
Because STAT1/ mice exhibited dysregulation of the TH1
and TH2 responses, we examined the possibility that the re-
cently described TH17 lineage could also be perturbed in these
animals. These cells contribute to pathogenesis in asthma and
chronic inflammation (49, 73, 81) and could be relevant to the
ongoing pathogenesis observed in STAT1/ mice. Although
induction of TH17 cytokine gene Il17a was negligible in WT
and IFNAR1/ mice, expression of this gene was strongly
induced at 9 dpi in STAT1/ mice (averaging 86-fold by
microarray and 1,600-fold by RT-PCR) (data not shown).
Likewise, the expression of Il23a, a cytokine responsible for
survival of TH17 cells, was induced 4-fold (based on microarray
data) in STAT1/ animals at 9 dpi. These results suggest that
activation of the TH17 pathway occurs concurrently with the
development of fibrosis in STAT1/ mice.
Effect of the TH2 bias on macrophage phenotype. Previous
studies have suggested that macrophage phenotypes play a role
in TH2-mediated fibrosis (2, 25, 51). In response to viral or
bacterial pathogens, macrophages become activated by gamma
interferon along a classical pathway (M1 macrophages). These
cells are characterized by production of proinflammatory cy-
tokines as well as nitric oxide synthase (45). Gene expression
for individual M1-associated genes was strong at 2 dpi in all
mouse strains studied (Fig. 7B). This gene expression de-
creased in the WT and IFNAR1/ mice at 5 and 9 dpi as
these strains cleared the virus. In contrast, M1 gene expression
remained elevated in STAT1/ mice, reflecting sustained in-
fection in these animals.
Under certain circumstances, such as response to helminth
infections, macrophages (specifically, M2 macrophages) can
become activated by Il4 along an alternative pathway. These
AAMs are characterized by production of arginase I, Il10,
eosinophilic chemokines, and insulin-like growth factor-1. In-
creased expression of individual M2-associated genes, includ-
ing arginase I, Ccl24, Cd14, and Il8rb by 2 dpi and Ccl1, Igf1,
and Ccr2 by 5 dpi, revealed strong activation of the M2 re-
sponse only in STAT1/ animals (Fig. 7B, cyan box). This
pattern of gene expression was also confirmed using RT-PCR
for Arg1 and Igf1 (data not shown).
Lungs of STAT1/ mice exhibit macrophage infiltration
and activation along the alternative pathway. To confirm the
production of arginase I by M2 macrophages in STAT1/
mice, we performed immunohistochemistry to detect several
protein markers of alternative macrophage activation: arginase
I, Ym1, and Mac3. As shown in Fig. 8, minimal staining was
detected in the lungs of mock-infected animals. By 9 dpi, both the
number of cells staining for these proteins and the density of the
staining had increased in STAT1/ mice. Increased staining was
also observed at 2 and 5 dpi (data not shown). Of particular
interest, the cells exhibiting high levels of staining exhibited mor-
phology characteristics consistent with macrophages. These re-
sults extend our gene expression data, suggesting that, in
STAT1/ mice, arginase I-expressing M2 macrophages infiltrate
the lung in large numbers during rMA15 infection.
To confirm that lung macrophages were being activated
along the alternative pathway, we performed flow cytometry
using antibodies to CD11b and CD14 to identify macrophages
and Mac3 to identify AAMs (A. Q. Ford, P. Dasgupta, E. A.
Smith, N. Noben-Trauth, and A. D. Keegan, submitted for
publication). Numbers of AAMs remained low in strain 129
mice and uninfected STAT1/ mice. However, STAT1/
mice infected with rMA15 exhibited a dramatic increase in the
population of AAMs (Fig. 9A) as well as in the number of
AAMs as a percentage of total macrophages (Fig. 9B). Based
on these data, we conclude that AAMs are disproportionately
activated in STAT1/ mice infected with rMA15.
FIG. 7. Increased TH2- and M2-associated gene expression in
STAT1/ mice. (A and B) Expression profiles are shown for genes
associated with TH1 and TH2 responses (A) and for M1 classical
macrophage activation and M2 alternative macrophage activation (45)
(B). Individual genes are identified by the mouse Entrez Gene name.
TH2 responses and M2 responses were upregulated only in STAT1
/
mice and are highlighted by yellow and cyan boxes, respectively.
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DISCUSSION
Previous studies have demonstrated that SARS-CoV infec-
tion of mice mirrors the acute exudative phase of ARDS (63,
64). More recently, STAT1/ mice were shown to be highly
susceptible to rMA15 infection, whereas disruption of inter-
feron signaling at the level of the type I, II, or III interferon
receptors did not significantly alter the disease course from
that observed in WT mice (24). Our current gene expression
analyses further demonstrate that although there were differ-
ences in the transcriptional profiles of WT and IFNAR1/
mice, signaling through the type I interferon receptor was not
necessary for a protective antiviral transcriptional response
during rMA15 infection. Other studies performed by our
group have revealed that IFNAR1/ mice, and mouse em-
bryonic fibroblasts derived from these animals, also induce ISG
expression in response to infection with influenza virus (14,
27), suggesting that there exists a common mechanism of com-
pensation for the loss of type I interferon receptor signaling.
Our results also reveal molecular mechanisms by which
STAT1/ mice progress to fibrosis-like disease, mirroring the
exudative and fibrotic phases of ARDS.
Compensatory gene expression in IFNAR1/ mice. Al-
though WT and IFNAR1/ mice exhibited similar weight loss
and pathology characteristics, absence of the type I interferon
receptor was associated with changes in host gene expression
with respect to the immune response and healing. For exam-
ple, at 2 dpi, a large number of genes associated with metab-
olism exhibited decreased expression in IFNAR1/ mice (Ta-
ble 2). Similar metabolic changes have been observed in
response to a variety of viral infections, suggesting that this is
an additional protective response to viral infection (3, 8, 13).
Although genes associated with mitosis were induced in WT
and IFNAR1/ mice at 5 dpi, IFNAR1/ mice exhibited
greater induction of these genes, particularly those associated
with DNA damage repair. In addition, we observed a slight
attenuation of ISG expression in IFNAR1/ mice compared
with WT mice (Fig. 5). This attenuation may be responsible for
the larger viral load observed in the lungs of IFNAR1/ mice
at 5 dpi compared with that observed in WT mice at the same
time point (24). This compensatory ISG activation was poten-
tially the result of interferon lambda signaling, but only modest
induction of Il28b (interferon lambda 3) was observed in the
FIG. 8. Detection of AAM markers in lung tissue of infected
STAT1/ mice by the use of immunohistochemistry. Lung sections
were stained for the AAM markers arginase I, Ym1, and Mac3 with a
hematoxylin counterstain. At 9 dpi, prominent staining is observed in
STAT1/ mice infected with rMA15 compared with uninfected ani-
mals and WT animals infected with rMA15. Magnification, 40.
FIG. 9. Enrichment of alternatively activated macrophages in
STAT1/ mice infected with SARS-CoV. Ten-week-old strain 129
WT and STAT1/ mice were infected with MA15, and their induction
of AAMs was analyzed at 8 days postinfection. A total of 50,000 lung
cells were sorted for the total macrophage population according to the
presence of CD11b and CD14 double positives. Of these cells, AAMs
were identified by the presence of Mac3 in the cells by intracellular
staining. (A) The numbers of CD11b, CD14, and MAC3 cells are
graphed. (B) The numbers of AAMs are graphed as percentages of the
total number of macrophages (CD11b/CD14 cells).
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lungs of all strains at 2 dpi. However, Frieman et al. showed
that mice with defects in both type I and type III interferon
signaling cleared rMA15 infection, suggesting the presence of
additional compensatory pathways (24). We also cannot rule
out the possibility that induction of some ISGs was the result of
secondary signaling through other pathways, including that
involving interferon gamma. However, Frieman et al. showed
that interferon gamma signaling was also dispensable for clear-
ing rMA15 (24). Through redundant pathways, some defects in
innate immunity can be overcome, including removal of type I
interferon signaling. By comparison, there was a dramatic re-
duction of ISG expression in rMA15-infected STAT1/ mice;
this reduction correlated with increased pathology and death
for these animals. Since many immune response pathways,
including the interferon response, signal through STAT1, the
STAT1/ mice appear to be unable to mount an effective
antiviral response to rMA15 infection.
Macrophage dysregulation in STAT1/ mice. Our gene
expression data suggest that infection of STAT1/ mice with
rMA15 dysregulates TH1/TH2 and macrophage host responses,
resulting in a profibrotic phenotype. A model consistent with
our data is shown in Fig. 10. In WT and IFNAR1/ mice (but
not STAT1/ mice), T cells that differentiate with a TH1
program repress TH2 differentiation via gamma interferon sig-
naling through STAT1 (82). Gamma interferon also stimulates
the differentiation of macrophages along a classical activation
pathway (M1) characterized by production of interleukins 1
and 6, tumor necrosis factor, and Cxcr3 ligands (Cxcl9, Cxcl10,
and Cxcl11) (45); upregulation of these genes was observed in
WT and IFNAR1/ mice at 2 dpi.
In contrast, we found that STAT1/ mice exhibited a TH2-
biased immune response to infection with rMA15. TH2 cells
produce Il4 (production of which was transcriptionally in-
creased in STAT1/ mice infected with rMA15), which trig-
gers the differentiation of macrophages along an alternative
activation pathway (M2). Alternatively activated macrophages
were observed at 2 dpi in STAT1/ mice, and their numbers
increased at 5 and 9 dpi. The TH2/M2 response is associated
with a variety of biological functions, including wound healing,
chronic inflammation, and fibrotic immune responses to hel-
minths (15, 66, 78). Notably, similarities with respect to
TH2/M2 bias and pulmonary fibrosis have been observed in
gamma interferon receptor knockout (IFNGR/) mice in-
fected with murine gammaherpesvirus 68 (51). In contrast, we
did not observe fibrosis in IFNGR/ mice infected with
rMA15 (24). This could have been due either to inhibition of
uncontrolled cell proliferation by STAT1 (76) or to effective
clearance of the virus in these mice.
Thus, a signaling pathway that promotes healing under fa-
vorable conditions may instead promote fibrosis in the context
of continuing immune dysregulation, uncontrolled fibroblast
proliferation, and/or persistent viral replication (Fig. 10). One
hallmark of M2 macrophages is the production of arginase I
(31), which regulates the first committed step in the conversion
of arginine to proline (42). Proline is an important building
block for collagen production, so increases in proline concen-
trations are considered profibrotic. It is interesting that, al-
though arginase I was strongly induced transcriptionally at all
time points in STAT1/ mice, we observed a lag in the pro-
duction of arginase I protein in the lung (Fig. 8). Likewise,
genes in a panel associated with fibrosis progression (Fig. 6)
were differentially induced in STAT1/ mice prior to the
appearance of protein deposition in the lungs. Similar results
have also been found in the context of hepatic cell apoptosis
and fibrosis (68). These results suggest the potential for diag-
nostic tests to detect gene expression changes predictive of the
initiation of fibrosis.
STAT1/ mice also exhibited increased expression of ad-
ditional M2 macrophage-associated genes that contribute to
fibrosis and eosinophilia. For example, we observed increased
expression of Igf1, an important regulator of cell proliferation
(65) that promotes fibroblast survival and increased extracel-
lular matrix protein deposition (79). It is negatively regulated
by several IGF-binding proteins (Igfbp1 through Igfbp6), and
expression of genes encoding these proteins was decreased in
STAT1/ mice in response to rMA15 infection (data not
shown). In addition, we observed increased expression of
Mmp9 and Mmp12, which are expressed by M2 macrophages
to promote wound healing (56) and tissue remodeling (33),
respectively.
Contribution of eosinophils and TH17 cells. TH2-mediated
inflammation causes eosinophil infiltration, which is generally
not observed during acute viral infection. Mmp12 is an impor-
tant contributor to airway eosinophilia in mice (60), and eo-
sinophilia is associated with pulmonary fibrosis in humans (21)
and with ARDS (35) and is also observed in some cases of
persistent inflammation. Expression of genes encoding eosin-
ophil attractants, including Ccl11, Ccl24, and Mmp12, was
observed in STAT1/ mice as early as 2 dpi, and significant
eosinophilia was observed at 8 dpi (24).
TH17 cells are a recently described T-helper population dis-





















FIG. 10. Dysregulation of T-helper and macrophage differentiation
in STAT1/ mice. A functional network that depicts the effects of
T-helper differentiation on macrophage phenotype and disease reso-
lution is shown. The regulation of genes associated with TH1, TH2, M1,
and M2 is represented with red arrows to indicate upregulation or with
a gray bar to indicate no significant change from mock-infected animal
results. A heat map is shown for select macrophage-associated genes
that contribute to fibrosis and eosinophilia. Genes are colored accord-
ing to differential regulation at 9 dpi.
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asthma, chronic obstructive pulmonary disease, and autoim-
mune inflammation (30, 36, 53, 73, 81). As with eosinophilia,
the presence of TH17 cells, which mediate inflammation
through the production of Il17 and Il23, is not characteristic of
most acute viral infections. However, gene expression charac-
teristic of TH17 cells was observed in STAT1
/ mice at 9 dpi.
As with TH2, TH17 differentiation is repressed by gamma in-
terferon signaling through STAT1 (57), suggesting that re-
moval of this block in STAT1/ mice enables the expansion
of TH17 cells. The occurrence of eosinophils and TH17 cell
markers in the lungs of STAT1/ mice at 8 to 9 dpi suggests
that these cells may play a role in the later progression rather
than the initiation of fibrosis, although this has not been di-
rectly examined.
Comparison of rMA15-infected STAT1/ mice with other
SARS-CoV models. This is the first report of a study examining
the host transcriptional responses elicited by the mouse-
adapted rMA15 variant of SARS-CoV in young mice. The
disease course caused by rMA15 infection in young strain 129
mice was similar to that observed in aged BALB/c mice in-
fected with SARS-CoV Urbani (63). Of particular interest, a
comparison of TH2 and M2 gene expression characteristics in
aged and young BALB/c mice (63) reveals greater induction of
Il13ra1, Ccl5, Ccl7, Fcer1g, and Igf1 in aged mice, suggesting
that TH2 and M2 induction upon viral infection is a common
feature of aged BALB/c and STAT1/ mice. In contrast,
induction of TH17-associated genes was not observed in aged
BALB/c mice infected with SARS-CoV. In addition, previously
described SARS-CoV mouse models that used stain rMA15 or
Urbani (62–64, 67) exhibited either mortality or recovery from
infection within 6 dpi. In contrast, STAT1/ mice did not
succumb to the infection until approximately 10 dpi and ex-
hibited protein deposition in the lungs consistent with fibrosis.
This suggests that rMA15-infected STAT1/ mice represent a
model of both the exudative and the organizing (fibrotic)
phases of ARDS pathophysiology (61).
Previous transcriptome analysis of blood samples from pa-
tients suffering from SARS-CoV infection suggested that sus-
tained innate immune activation and a failure to switch to
humoral immunity are associated with a severe disease course
(6). STAT1/ mice exhibited a similar sustained, yet ineffec-
tive, immune response. However, these clinical cases exhibited
gene expression more characteristic of the type I interferon
response and not of the TH2, M2, and TH17 cell expression
observed in STAT1/ mice. These differences may reflect the
choice of tissue used for microarray analysis (Cameron and
coworkers used blood from patients whereas our analysis used
lung tissue), but they could also be the result of the profound
dysregulation associated with the loss of STAT1-dependent
transcription. However, similar TH2 bias and macrophage dys-
regulation characteristics have been observed in aged human
populations (26, 59), members of which are more susceptible
to pulmonary fibrosis (44) and exhibited greater mortality rates
during the SARS outbreak (9). Based on these common fac-
tors, STAT1/ mice may be a good model for investigation of
the SARS-dependent initiation of fibrosis observed in aged
populations.
In conclusion, rMA15 infection of STAT1/ mice resulted
in an aberrant TH2 response, sustained viral infection, inflam-
mation, and a profibrotic phenotype. This infection system
serves as a model for the early and intermediate stages of
ARDS and should be of value for the testing of therapeutic
interventions to alleviate virus-induced ARDS. In addition,
this model may be useful for studying the role of eosinophils
and TH17 cells in mediating persistent inflammation in re-
sponse to viral infection.
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